MATERNAL SERUM ALPHA‐FETOPROTEIN AND PREVIOUS NEURAL TUBE DEFECTS
- 1 March 1976
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 83 (3) , 213-216
- https://doi.org/10.1111/j.1471-0528.1976.tb00811.x
Abstract
A case-control study involving 63 pregnancies showed that women who had previously had an infant with anencephaly or spina bifida did not have raised serum alpha-fetroprotein (AFP) levels in subsequent unaffected pregnancies. The value of a serum AFP determination in such women is discussed. If the serum AFP level is normal and if ultrasonography excludes anencephaly the risk of spina bifida might be low enough (about 1 per cent) to make diagnostic amniocentesis difficult to justify. Conversely, a high serum AFP value in such women should not be acted on without confirmation of an abnormality by ultrasonography and, if that is negative, by diagnostic amniocentesisKeywords
This publication has 6 references indexed in Scilit:
- EFFECT OF GESTATIONAL AGE ON SCREENING FOR NEURAL-TUBE DEFECTS BY MATERNAL PLASMA-A.F.P. MEASUREMENTThe Lancet, 1975
- Maternal serum alpha-fetoprotein levels in multiple pregnancy.BMJ, 1975
- Editorial: Antenatal diagnosis of spina bifida.BMJ, 1975
- CAUSATION OF NEURAL TUBE DEFECTS: CLUES FROM EPIDEMIOLOGYBritish Medical Bulletin, 1974
- PRENATAL DIAGNOSIS OF SPINA BIFIDA AND ANENCEPHALY BY MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENT: A Controlled StudyThe Lancet, 1974
- PRENATAL DIAGNOSIS OF SPINA BIFIDA AND ANENCEPHALY THROUGH MATERNAL PLASMA-ALPHA-FETOPROTEIN MEASUREMENTThe Lancet, 1974